Dose-adjusted bendamustine as a replacement for carmustine in autologous stem cell transplant conditioning for patients with relapsed lymphoma: a retrospective single-center study
Publication date: Available online 24 November 2020Source: Hematology/Oncology and Stem Cell TherapyAuthor(s): Naif I. AlJohani, Momen Nasani, Hosam E. Ahmed, Jalil Ur Rehman, Azhar Nawaz, Zayed Alzahrani, Bassim Albeirouti
Source: Hematology Oncology and Stem Cell Therapy - Category: Cancer & Oncology Source Type: research
More News: Cancer & Oncology | Hematology | Lymphoma | Stem Cell Therapy | Stem Cells | Study | Transplants | Treanda